UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Keith Heinzerling, MD

Print
Email

Keith Heinzerling, MD

UCLA Physician Keith Heinzerling, MD specializes in Addiction Medicine, Internal Medicine.
Specialty
Addiction Medicine, Internal Medicine
Gender
Male
Language Spoken
English
Hospital Affiliation
UCLA Medical Center, Santa Monica
State License Number
A79201
Contact
(310) 319-4700 Information and referral
Fax Number
(310) 453-5106 Referrals
Follow me on ShareCare
PRACTICE LOCATION
UCLA Family Center Center
1920 Colorado Avenue
Santa Monica, CA 90404

Request an Appointment with Dr. Heinzerling »

MEDICAL BOARD CERTIFICATION
Internal Medicine, American Board of Internal Medicine, 2001, 2012
EDUCATION
Fellowship
, UCLA GIM and Health Services Research, 2002 - 2005
Residency
Internal Medicine, New York University School of Medicine, 1999 - 2002
Internship
Internal Medicine, New York University School of Medicine, 1998 - 1999
Medical Degree
MD, Stanford University School of Medicine, 1993
AFFILIATION
Department Affiliation
Physician, Center for Behavioral and Addiction Medicine
MORE INFORMATION
Research Interest
Addiction Medicine in Primary Care; Development of Anti-Addiction Medications; Clinical Trials
Additional Information
UCLA Center for Behavioral and Addiction Medicine (CBAM), Medical Director
Publications

Bluthenthal RN, Heinzerling KG, Martinez A, Kral AH. Police Crackdowns, Societal Cost, and the Need for Alternative Approaches. International Journal of Drug Policy, Volume 16, Issue 3, pages 137-138, June 2005.

Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. Unmet Need for Recommended Preventive Health Services Among Clients of California Syringe Exchange Programs: Implications for Quality Improvement. Drug and Alcohol Dependence, Volume 81, Number 2, pages 167-178, February 1, 2006.

Heinzerling KG, Etzioni DA, Hurley B, Holtom P, Bluthenthal RN, Asch SM. Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban Versus Rural Counties in California. Journal of Urban Health, Volume 83, Number 2, pages 176-181, March 2006. Heinzerling KG, Shoptaw S, Peck JA, Yang X, Liu J, Ling W. Randomized, Placebo-Controlled Trial of Baclofen and Gabapentin for the Treatment of Methamphetamine Dependence. Drug and Alcohol Dependence, Volume 85, Number 3, pages 177-184, December 1, 2006.

Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. HIV and Hepatitis C Testing at Syringe Exchange Programs: Availability and Outcomes, Journal of Substance Abuse Treatment, Volume 32, Number 4, pages 423-429, June 2007.

Bluthenthal RN, Heinzerling KG, Gilbert ML, Anderson R, Flynn NM, Scott A, Kral AH. Legalization of syringe exchange programs in California: Mixed results from a local approach to HIV prevention. American Journal of Public Health, Electronic Publication, May 30, 2007.

Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Kao UH, Wang PC, Bholat M, Ling W. Bupropion Hydrochloride Versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence, Journal of Addictive Diseases, in press.

Link to pubmed publications »

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Keith Heinzerling,  click here to update your profile.